BioAtla Inc
(NAS:BCAB)
$
1.5
-0.01 (-0.66%)
Market Cap: 72.17 Mil
Enterprise Value: -6.29 Mil
PE Ratio: 0
PB Ratio: 1.46
GF Score: 35/100 BioAtla Inc (BCAB) Transcripts
- Q1 2024 Bioatla Inc Earnings Call TranscriptMay 14, 2024$2.61 (-1.14%)Earnings
- Q4 2023 Bioatla Inc Earnings Call TranscriptMar 26, 2024$3.01 (+29.18%)Earnings
- Bioatla Inc at JPMorgan Healthcare Conference TranscriptJan 11, 2024
- Bioatla Inc R&D Day TranscriptDec 13, 2023
- Q3 2023 Bioatla Inc Earnings Call TranscriptNov 07, 2023$1.76 (-4.35%)Earnings
- Bioatla Inc at HC Wainwright Investment Conference - New York(Pre Recorded) TranscriptSep 11, 2023
- Bioatla Inc at HC Wainwright Immune Cell Engager Virtual Conference TranscriptAug 17, 2023
- Q2 2023 Bioatla Inc Earnings Call TranscriptAug 01, 2023$2.88 (-3.68%)Earnings
- Bioatla Inc at Jefferies Healthcare Conference TranscriptJun 07, 2023
- Bioatla Inc at JMP Securities Life Sciences Conference TranscriptMay 15, 2023
- Q1 2023 Bioatla Inc Earnings Call TranscriptMay 11, 2023$3.21 (-3.02%)Earnings
- Q4 2022 Bioatla Inc Earnings Call TranscriptMar 23, 2023$2.3 (-1.71%)Earnings
- Q3 2022 Bioatla Inc Earnings Call TranscriptNov 03, 2022$6.36 (-1.40%)Earnings
- Q2 2022 Bioatla Inc Earnings Call TranscriptAug 09, 2022$3.61 (-3.48%)Earnings
- Q1 2022 Bioatla Inc Earnings Call TranscriptMay 04, 2022$4.08 (+6.53%)Earnings
- 1